Precog, Llc.
Clinical trials sponsored by Precog, Llc., explained in plain language.
-
New drug combo aims to boost immune attack on tough lung cancer
Disease control Recruiting nowThis study tests a new drug called ivonescimab, given with standard chemotherapy, for people with extensive-stage small cell lung cancer who haven't had treatment yet. Ivonescimab is a special antibody that helps the immune system fight cancer and may also block blood vessels tha…
Phase 2 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New hope for myeloma patients: could a smart drug outperform standard therapy?
Disease control Recruiting nowThis phase 3 trial will compare two drug combinations for people newly diagnosed with multiple myeloma who are not eligible for or refuse a stem cell transplant. About 500 participants will receive either belantamab mafodotin or daratumumab, both combined with standard drugs (bor…
Phase 3 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC